combin
antiretrovir
therapi
fail
complet
suppress
due
drug
resist
persist
latenc
novel
therapeut
intervent
requir
knowledg
intracellular
pathway
respons
viral
replic
specif
untarget
antiretrovir
drug
understudi
phenomenon
nucleolar
local
rev
phosphoprotein
complet
nucleocytoplasm
transport
unsplicedparti
splice
hiv
mrna
multimer
intron
cisact
targetsth
revrespons
element
rre
rev
contain
nucleolar
local
signal
nol
compris
cooh
terminu
argininerich
motif
accumul
within
nucleolispecul
interact
ground
rev
cellular
protein
mediat
mrnaindepend
nuclear
export
splice
function
rev
nucleolar
access
product
infect
investig
context
delet
singlepoint
mutat
within
revnol
mutat
induc
upon
revnol
hypothes
inactiv
infecti
cycl
replic
ceas
rev
mutat
lack
nucleolar
access
due
loss
replac
multipl
arginin
residu
rev
mutat
miss
singl
arginin
residu
remain
strictli
nucleolar
pattern
particip
provir
product
howev
reduc
effici
viral
rna
packag
also
decreas
effici
express
nucleolarloc
mutat
result
observ
propag
variant
contain
nucleolarloc
mutat
within
viral
backbon
lentivir
particl
produc
rev
singlepoint
mutat
transduc
extrem
low
frequenc
similarli
revnol
variant
lost
infect
unlik
virul
wt
wild
type
variant
capabl
host
entri
revers
transcript
wt
lack
abil
complet
full
infecti
cycl
current
reveal
viral
integr
deregul
presenc
revnol
mutat
n
underexplor
area
research
nucleolar
pathway
viral
protein
tat
rev
particip
viral
prolifer
unlik
tat
accumul
nucleu
nucleolu
rev
mainli
nucleolar
subcellular
local
upon
viral
infect
hiv
genom
revers
transcript
provir
integr
host
chromosom
lead
cellular
pol
iidepend
earli
express
envderiv
protein
tat
rev
nef
tat
facilit
transcript
express
viral
gene
associ
transactiv
respons
element
tar
found
within
ltr
hiv
transcript
rev
achiev
nucleocytoplasm
transport
hiv
mrna
recognit
revrespons
element
rre
conform
within
env
conform
involv
rev
bind
site
iib
ia
compos
opposit
leg
shape
argininerich
motif
arm
rev
monom
bind
iib
high
affin
expos
dimer
interfac
second
rev
monom
bind
rev
monom
achiev
multimer
throughout
rre
mainli
within
nucleolu
nuclear
export
revrr
rnp
ribonucleoprotein
complex
occur
rev
nuclear
export
signal
ne
interact
chromosom
region
mainten
gtpbound
ran
lead
accumul
introncontain
unsplic
kb
fulllength
genom
contain
gagpol
partial
splice
kb
fragment
contain
vif
vpr
vpu
env
hiv
transcript
cytoplasm
viral
protein
express
viral
particl
assembl
transcript
previous
identifi
nucleolu
infect
peripher
blood
mononuclear
cell
pbmc
electron
microscopi
situ
hybrid
probe
complementari
gag
env
nef
nucleolar
therapeut
model
henc
develop
product
util
hammerhead
ribozym
place
within
small
nucleolar
rna
platform
target
conserv
motif
within
express
hela
nucleolar
specif
observ
upon
hiv
challeng
nucleolar
strongli
suppress
product
select
cleav
unsplic
partial
splice
transcript
travers
nucleolu
sequest
ribozym
similarli
modifi
target
gag
significantli
reduc
viral
product
cem
hiv
challeng
potent
catalyt
activ
nucleolarspecif
hiv
rrecontain
transcript
suggest
nucleolar
pathway
facilit
rev
nucleocytoplasm
activ
dynam
multifunct
nucleolar
proteom
enabl
ribosom
subunit
biosynthesi
cell
cycl
control
apoptosi
dna
replicationrepair
rnp
biogenesi
stress
respons
within
subnucleolar
compartmentsfibrillar
center
dens
fibrillar
compon
dfc
outermost
granular
compon
gc
viral
pathogenesi
induc
cellular
stress
lead
transform
nucleolar
proteom
morpholog
nucleolaraccess
viral
protein
recruit
replic
factor
similar
rev
follow
singlestrand
rna
virus
express
nucleolar
rna
bind
protein
divers
function
sever
acut
respiratori
coronaviru
nucleocapsid
n
harbor
ne
predict
nucleocytoplasm
shuttl
activ
dengu
viru
core
protein
facilit
encapsid
potenti
modul
transcript
semliki
forest
viru
nonstructur
protein
regul
viral
mrna
synthesi
although
nucleolar
traffick
preval
mani
viral
infecti
model
purpos
local
pattern
unknown
case
nucleolu
may
serv
interact
ground
rev
cellular
protein
facilit
rapid
mrna
nuclear
export
protect
hiv
mrna
spliceosom
complex
rev
subnucleolar
local
within
dfc
gc
occur
nucleolar
local
signal
nol
wrerqrq
directli
downstream
nuclear
local
sequenc
nl
trqarrnrrrr
within
rev
arm
rev
nucleolar
local
origin
demonstr
occur
amino
acid
within
rev
nl
studi
cochran
et
al
later
identifi
amino
acid
residu
within
rev
arm
vital
nucleolar
accumul
use
sitedirect
mutagenesi
alter
amino
acid
surround
rev
nl
indirect
immunofluoresc
rev
local
mutat
lack
amino
acid
rqrq
maintain
nucleolar
accumul
absenc
hiv
product
howev
delet
expand
residu
wre
result
complet
elimin
wrerqrq
amino
acid
nuclear
accumul
observ
although
potenti
revnol
identifi
amino
acid
downstream
nl
function
rev
nucleolar
mutat
investig
context
product
infect
character
rev
nucleolar
function
product
infect
examin
presenc
rev
nucleolar
mutat
current
reveal
rev
nucleolar
access
necessari
complet
infecti
cycl
nucleolar
activ
allow
effici
mrna
splice
nucleocytoplasm
transport
background
rev
nucleolar
mutat
frequenc
viral
integr
increas
dramat
comparison
wt
wild
type
extrem
integr
frequenc
result
cell
death
arrest
infecti
cycl
demonstr
loss
rev
interact
result
nucleolar
mutat
discuss
involv
viral
infecti
model
requir
nucleolar
access
infect
hela
cell
contain
stabli
integr
copi
revdefici
molecular
clone
hlfb
obtain
nih
aid
research
refer
reagent
program
hlfb
hela
american
type
cultur
collect
hela
human
embryon
kidney
human
fibrosarcoma
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
mm
sodium
pyruv
within
humidifi
chamber
co
jurkat
report
cell
nih
aid
research
refer
reagent
program
express
receptor
coreceptor
cell
lymphoblast
cem
maintain
supplement
fb
mm
lglutamin
mm
sodium
pyruv
uml
penicillin
lgml
streptomycin
cmvdriven
revegfp
fusion
within
pcdna
platform
templat
quickchang
ii
sitedirect
mutagenesi
agil
technolog
primer
sequenc
design
accord
mutat
interest
within
revnol
tabl
primer
sequenc
tabl
also
use
gener
rev
mutat
within
singlepoint
mutat
delet
confirm
dna
sequenc
revnol
fragment
bp
excis
nih
aid
research
refer
reagent
program
use
nhei
bamhi
restrict
digest
ligat
restrict
fragment
templat
sitedirect
mutagenesi
use
primer
set
tabl
design
establish
mutat
revnol
specif
mutantposit
fragment
excis
reintroduc
backbon
dna
sequenc
use
confirm
presenc
revnol
mutat
delet
wt
contain
reintroduc
nonmut
revnol
restrict
fragment
ligat
alongsid
singlepoint
mutant
fragment
bacteri
coloni
pcr
screen
use
forward
primer
specif
revnol
mutat
tabl
combin
env
revers
primer
use
amplifi
follow
mutant
clone
dna
sequenc
use
confirm
presenc
mutat
cdna
fragment
within
restrict
digest
setsbbvci
ahdi
draii
pstiwer
use
analyz
wt
chromosom
rearrang
use
origin
plasmid
control
restrict
digest
setsbbvci
ahdi
draiii
pstiwer
use
next
analyz
mutat
chosen
propag
viral
particl
subject
final
analysi
chromosom
rearrang
three
restrict
digest
setspsti
draiii
bbvci
ahdi
ndei
ahdi
supplementari
fig
c
mutant
plasmid
match
digest
fragment
pattern
wt
use
propag
particl
hlfb
hela
cell
cultur
onto
polyllysinetr
cultureslid
falcon
cell
transfect
follow
day
lg
revnolsegfp
mutat
use
lipofectamin
reagent
invitrogen
cell
fix
h
later
paraformaldehyd
permeabil
triton
block
fb
h
room
temperatur
mous
monoclon
igg
santa
cruz
biotechnolog
dilut
fb
incub
cell
h
cell
wash
triplic
phosphatebuff
salin
pb
subject
incub
alexa
fluor
goatantimous
igg
dilut
cell
rins
stain
dapi
lg
ml
sigmaaldrich
min
glass
cover
slip
mount
onto
cell
use
prolong
gold
antifad
reagent
invitrogen
store
dark
imag
taken
zeiss
upright
microscop
magnif
oil
immers
zoom
hlfb
cell
cell
grown
sixwel
tissu
cultur
plate
confluenc
transfect
lg
vector
plasmid
contain
revegfp
wt
mutat
use
cacl
method
supplement
dmem
ml
replac
h
later
viralcontain
supernat
collect
h
posttransfect
centrifug
rpm
min
remov
cell
debri
viral
supernat
quantifi
capsid
protein
use
elisa
perkinelm
life
scienc
inc
rna
packag
viral
particl
gener
presenc
revnol
mutat
analyz
packag
rna
use
quantigen
bdna
detect
affymetrixpanom
solut
use
probe
set
specif
highli
conserv
region
within
vif
affymetrix
inc
cdna
harbor
revnol
mutat
transfect
confluent
cacl
lg
well
within
cultur
plate
viral
supernat
collect
h
later
clear
cell
debri
quantifi
product
viral
supernat
normal
ng
use
infect
precultur
cell
per
well
cell
wash
thrice
hbss
h
infect
resuppl
rpmi
media
assess
infect
mutant
variant
cell
collect
everi
day
stain
livedead
aqua
dead
cell
stain
life
technolog
fix
paraformaldehyd
measur
aqua
fluoresc
nm
excit
cyan
adp
color
fac
analysi
live
cell
analyz
infect
egfp
emiss
nm
excit
supernat
wt
revnol
mutationswa
normal
ng
capsid
infect
popul
cell
per
well
cultur
plate
infect
cell
wash
suspens
hbss
thrice
h
viral
exposur
replenish
rpmi
media
cell
harvest
everi
day
genom
dna
extract
use
qiaamp
dna
mini
kit
qiagen
amplif
total
circl
dna
achiev
use
lg
genom
dna
subject
pcr
primer
set
lm
final
volum
anneal
condit
describ
posit
control
fragment
deriv
pcr
amplif
genom
dna
hivinfect
cem
total
hiv
dna
infect
cem
treat
integras
inhibitor
circl
nih
aid
research
refer
reagent
program
lm
final
volum
primer
set
specif
bglobin
geneforward
ttg
gac
cca
gag
gtt
revers
gca
ctt
tct
tgc
cat
use
amplif
gel
load
control
ident
anneal
condit
alongsid
total
circl
primer
set
use
cacl
follow
selfinactiv
sin
vector
lentivir
packag
plasmid
cotransfect
confluenc
lg
cgfp
lg
lg
pcmvg
lg
pcmvrevwt
nolsmut
lentivir
supernat
collect
concentr
previous
mention
five
hundr
picogram
supernat
use
transduc
polybren
transduct
llml
cell
grown
cell
per
well
plate
transduc
cell
collect
h
posttransduct
fix
paraformaldehyd
egfp
report
quantifi
use
cyan
adp
color
fac
analysi
northern
blot
analysi
mrna
splice
total
rna
transfect
lg
confluent
cm
cultur
plate
wt
revnol
variant
collect
h
later
use
rna
teltest
inc
accord
manufactur
instruct
forti
microgram
total
rna
electrophores
agaroseformaldehyd
ethidium
bromidestain
gel
transfer
onto
hybond
n
nucleic
acid
membran
ge
healthcar
rna
membran
ultravioletcrosslink
block
perfecthyb
plu
hybrid
buffer
sigma
h
hiv
rna
detect
use
pcramplifi
nef
fragment
origin
nucleotid
posit
amplif
accomplish
follow
primer
set
forward
primer
anneal
upstream
nef
introduc
uniqu
restrict
site
bamhi
cctagg
revers
primer
anneal
downstream
nef
introduc
uniqu
restrict
site
clai
tagcta
overnight
hybrid
nef
probe
radiolabel
p
dctp
use
rediprim
ii
dna
label
system
ge
healthcar
blot
rins
afterward
wash
buffer
contain
salin
sodium
citrat
ssc
sodium
dodecyl
sulfat
sd
min
thrice
final
wash
buffer
contain
ssc
sd
min
radiolabel
rna
membran
expos
biomax
ms
film
kodak
overnight
develop
detect
rna
fragment
rel
densiti
splice
fragment
analyz
use
imagej
softwar
http
rsbweb
nihgovij
cdna
lg
wt
revnol
mutat
coexpress
lg
pegfpvpr
nih
aid
research
refer
reagent
program
confluent
within
sixwel
cultur
plate
cacl
transfect
media
replac
ml
supplement
dmem
h
later
viral
supernat
collect
h
afterward
quantifi
level
one
microgram
viral
supernat
use
infect
confluent
cem
hela
seed
cultur
plate
h
cell
clear
viru
three
rins
pb
centrifug
rpm
preserv
paraformaldehyd
egfp
posit
quantifi
use
fac
arizala
et
al
rt
assay
viral
supernat
contain
wt
mutant
harvest
h
product
cell
supernat
lyse
releas
intravir
rt
rt
activ
measur
describ
revers
transcriptas
assay
colorimetr
kit
roch
creloxp
lentivir
dual
report
cell
grown
cm
tissu
cultur
plate
confluenc
sin
lentivir
backbon
contain
loxp
site
flank
cfp
report
rfp
report
directli
downstream
pbbxcxr
cotransfect
lg
packag
plasmid
describ
transfect
media
replac
ml
supplement
dmem
butyr
acid
h
posttransfect
lentivir
supernat
collect
h
later
titrat
polybren
transduct
llml
cellswel
plate
portion
transduc
collect
day
later
fix
paraformaldehyd
cfp
transduct
multipl
infect
one
viral
copi
per
cell
establish
cyan
adp
color
fac
popul
propag
sort
base
cfp
posit
stabl
bbxcxr
report
cell
use
bd
ariaii
sorp
coh
analyt
cytometri
facil
creloxp
recombin
report
cell
xcxr
transduc
lg
crevpr
lentiviru
cvitgcrevprirestatgfp
backbon
produc
wt
revnol
mutat
cfp
transit
rfp
lentivir
transduct
addit
gfp
fluoresc
integr
assess
bd
fortessa
cytomet
coh
analyt
cytometri
facil
preserv
paraformaldehyd
day
posttransduct
integras
lm
final
volum
rt
inhibitorazt
nih
aid
research
refer
reagent
program
lm
final
volum
serv
neg
control
cvitg
revers
transcript
integr
xcxr
report
cell
use
neg
control
rfp
gfp
cfp
express
integr
viral
dna
quantif
perform
use
alugag
pcr
describ
previous
total
genom
dna
isol
uninfect
pbmc
hivinfect
cell
use
qiaamp
dna
mini
kit
qiagen
amount
isol
human
genom
infect
sampl
determin
bglobin
pcr
use
itaq
univers
probe
supermix
biorad
pcr
reaction
perform
realtim
pcr
detect
system
biorad
cycl
follow
condit
primer
sequenc
follow
bglobin
fp
ttg
gac
cca
gag
gtt
bglobin
rp
gca
ctt
tct
tgc
cat
genom
concentr
sampl
calcul
use
standard
curv
obtain
known
dilut
pbmc
dna
genom
dna
sampl
dilut
lgml
quantif
integr
dna
perform
twostep
alugag
nest
pcr
first
step
reaction
perform
use
onetaq
master
mix
new
england
biolab
thermal
cycler
biorad
follow
condit
cycl
min
primer
sequenc
follow
alu
fp
gcc
tcc
caa
agt
gct
ggg
att
aca
gag
rp
cct
gct
atg
tca
ctt
product
first
step
reaction
subject
second
step
quantit
pcr
qpcr
quantifi
integr
viral
dna
qpcr
reaction
perform
realtim
pcr
detect
system
biorad
use
itaq
univers
probe
supermix
biorad
cycl
follow
condit
primer
sequenc
follow
fp
agc
ctc
aat
aaa
gct
tgc
rp
cgg
gcg
cca
ctg
cta
copi
number
integr
viral
dna
calcul
use
standard
curv
obtain
integr
standard
immunoprecipit
hlfb
grown
confluenc
sixwel
cultur
plate
cacl
transfect
lg
cdna
per
well
wt
revnol
mutat
total
protein
lysat
collect
h
later
lysi
buffer
mm
trishcl
ph
mm
nacl
tritonx
treat
proteas
inhibitor
cocktail
roch
one
milligram
per
millilit
protein
lysat
subject
ip
prerins
antiflag
affin
gel
sigmaaldrich
lysi
buffer
h
rotat
flag
bead
rins
afterward
lysi
buffer
boil
min
sampl
load
buffer
without
bmercaptoethanol
eluat
separ
antiflag
gel
analyz
western
immunoblot
protein
eluat
subject
sdspolyacrylamid
gel
electrophoresi
sdspage
acrylamid
gel
run
transfer
onto
pvdf
transfer
membran
ge
healthcar
incub
block
solut
milk
tb
tbst
h
room
temperatur
membran
submerg
primari
antibodi
dilut
block
mous
monoclon
igg
santa
cruz
biotechnolog
antiflag
mous
monoclon
igg
sigmaaldrich
overnight
rins
tbst
membran
incub
secondari
goatantimous
igg
horseradish
peroxidas
santa
cruz
biotechnolog
dilut
block
solut
h
room
temperatur
rins
tbst
protein
band
develop
enhanc
chemiluminesc
substrat
pierc
min
protein
chemiluminesc
detect
upon
exposur
biomax
ms
film
kodak
vari
time
point
rel
densiti
protein
signal
analyz
use
imagej
revnol
requir
two
arginin
residu
strict
nucleolar
access
product
rev
mutat
lack
four
amino
acid
residu
nl
ctermin
end
rqrq
previous
demonstr
maintain
nucleolar
local
pattern
cell
line
delet
mutat
extend
three
residu
upstream
wrerqrq
exhibit
nucleolar
misloc
replic
nucleolar
mutat
examin
local
pattern
presenc
hiv
product
revnol
mutat
contain
amino
acid
delet
singlepoint
substitut
arginin
residu
within
wrerqrq
gener
fuse
enhanc
green
fluoresc
protein
egfp
revegfp
fusion
variant
examin
intracellular
local
pattern
within
revdefici
provir
product
hlfb
fig
local
pattern
revegfp
fusion
variant
also
examin
absenc
viral
product
hela
supplementari
fig
supplementari
data
avail
onlin
wwwliebertpubcomaid
revnol
maintain
two
arginin
residu
delet
glycin
substitut
remain
strictli
nucleolar
pattern
wt
rev
fig
viral
product
absenc
nucleolar
pattern
similar
howev
includ
subnuclear
distribut
outsid
nucleolu
supplementari
fig
nol
mutat
presenc
product
hlfb
cell
stabli
express
revdefici
proviru
transfect
revegfp
mutat
green
fix
immunostain
nucleolar
control
red
treat
dapi
nuclear
stain
blue
revegfp
fusion
mutat
examin
intracellular
local
pattern
captur
magnif
oil
immers
zoom
repres
lm
scale
bar
similar
wt
rev
revnol
contain
singlepoint
nucleolar
access
similarli
revnol
retain
nucleolar
access
presenc
two
arginin
residu
b
absenc
two
arginin
residu
within
revnol
sequenc
caus
nuclear
nucleolar
dispers
nuclear
distribut
delet
nol
intracellular
local
upon
substitut
three
arginin
residu
within
nol
glycin
dapi
egfp
enhanc
green
fluoresc
protein
nol
nucleolar
local
signal
wt
wild
type
revnol
maintain
one
arginin
residu
delet
glycin
substitut
allow
nucleolar
entri
caus
nuclear
dispers
rev
fig
similarli
local
within
nuclei
nucleoli
absenc
supplementari
fig
revnol
miss
arginin
residu
delet
caus
nuclear
dispers
product
fig
intracellular
distribut
without
supplementari
fig
glycin
substitut
arginin
residu
result
nucleocytoplasm
distribut
rev
fig
nuclear
local
without
supplementari
fig
function
revnol
mutat
product
rna
packag
function
revnol
mutat
rescu
rev
defici
product
investig
hlfb
upon
express
wt
rev
gener
viral
particl
revegfp
nol
variant
introduc
hlfb
cell
viral
particl
collect
h
afterward
viral
output
capsid
protein
quantifi
enzymelink
immunosorb
assay
elisa
antigen
captur
assay
fig
revnol
mutat
exhibit
nonnucleolar
local
pattern
nucleu
cytoplasm
rescu
viral
product
simultan
nuclear
nucleolar
access
also
suffici
rescu
viral
product
singlepoint
mutat
retain
strict
nucleolar
access
rescu
viral
product
although
reduc
effici
compar
wt
revnol
contain
delet
two
amino
acid
residuesarginin
glutamin
drq
strictli
nucleolar
yet
nonfunct
pgml
normal
egfp
transfect
effici
fig
function
revnol
mutat
examin
without
egfp
fusion
revnol
mutat
contain
tag
express
hlfb
viral
supernat
collect
h
later
viral
product
capsid
protein
quantifi
elisa
antigen
captur
assay
similar
result
observ
without
egfp
tag
supplementari
fig
egfp
fusion
addit
tag
revnol
mutat
alter
function
rev
rev
mutat
next
test
abil
packag
viral
rna
use
branch
dna
bdna
colorimetr
assay
probe
specif
vif
revegfp
nol
variant
introduc
hlfb
cell
viral
particl
collect
h
afterward
intravir
rna
detect
particl
produc
nucleolarloc
rev
mutat
howev
less
effici
wt
rev
fig
nucleolarspecif
addit
nuclear
cytoplasm
mutat
particip
rna
packag
product
intravir
rna
repres
chemiluminesc
rel
light
unit
normal
egfp
transfect
effici
fig
revnol
mutat
without
egfp
fusion
examin
abil
packag
intravir
rna
revnol
mutat
contain
tag
express
hlfb
viral
supernat
collect
h
later
intravir
packag
rna
measur
use
bdna
colorimetr
assay
probe
specif
vif
similar
revegfp
nucleolarloc
singlepoint
mutat
revnol
except
revnol
abl
packag
intravir
rna
supplementari
fig
rescu
rna
packag
effici
wt
rev
mutat
shown
achiev
simultan
nuclearnucleolar
local
revnol
cytoplasm
local
revnol
lost
function
intravir
rna
packag
egfp
fusion
tag
addit
alter
abil
revnol
mutat
packag
intravir
rna
harbor
rev
nucleolar
singlepoint
mutat
unabl
complet
full
infecti
cycl
mutat
correspond
revnol
nucleolar
patternwer
induc
within
cdna
supplementari
fig
use
propag
viru
viral
supernat
collect
h
later
quantifi
capsid
elisa
antigen
captur
assay
singlepoint
mutat
within
backbon
prevent
viral
product
releas
fig
comparison
wt
viral
product
revnol
mutant
decreas
supernat
ng
subject
bdna
assay
use
vif
probe
specif
packag
genom
rna
singlepoint
mutat
within
backbon
prevent
genom
rna
packag
within
viral
particl
fig
comparison
wt
unabl
produc
viru
packag
genom
rna
effici
wt
particl
harbor
nucleolar
mutat
within
viral
backbon
examin
infect
stabli
express
ltregfp
induc
upon
tat
product
infect
abl
replic
infect
entir
cell
popul
fig
variant
infect
host
cell
extrem
low
frequenc
time
point
fig
quantif
infect
follow
wt
versu
variant
p
valu
p
valu
p
valu
column
repres
sampl
size
three
individu
infecti
process
unpair
ttest
abil
variant
gain
function
infecti
cycl
monitor
viral
output
viral
supernat
collect
interv
day
postinfect
unlik
infecti
wt
exhibit
activ
viremia
variant
lack
abil
fulli
regain
function
infect
day
postinfect
fig
also
evid
upon
examin
genom
dna
lentiviru
gener
nucleolarloc
rev
mutat
transduc
extrem
low
frequenc
lentivir
backbon
lack
follow
gene
gagpol
vif
vpu
env
nef
develop
previous
safe
deliveri
therapeut
gene
small
interf
rna
inhibit
infect
lentivir
vector
contain
gfp
report
quantif
transduct
event
fig
coexpress
packag
vector
includ
revnol
mutat
viral
supernat
collect
h
afterward
normal
pg
transduct
fig
rev
previous
shown
lack
function
viral
product
viral
rna
packag
analyz
neg
control
viral
particl
introduc
cell
transduc
cell
quantifi
h
later
use
egfp
fac
analysi
lentiviru
packag
revnol
mutat
exhibit
significantli
defect
transduct
comparison
lentiviru
packag
wt
rev
transduc
fig
column
repres
sampl
size
six
separ
transduct
event
unpair
ttest
fig
rev
singlepoint
nucleolar
mutat
lead
irregular
mrna
splice
nucleolar
mutat
interest
result
provir
product
revnol
examin
identifi
step
infecti
cycl
interrupt
presenc
revnol
mutat
mrna
splice
machineri
initi
examin
mrna
splice
depend
host
mrnasplic
machineri
produc
three
mrna
speci
express
protein
requir
viral
assembl
releaseunspl
kb
mrna
partial
splice
kb
mrna
fulli
splice
kb
mrna
upon
infect
viral
integr
host
genom
fulli
splice
viral
mrna
lead
express
tat
rev
nef
rev
turn
achiev
nucleocytoplasm
transport
rrecontain
rna
affin
involv
mrnaindepend
nuclear
export
pathway
rev
transport
partial
splice
viral
mrna
cytoplasm
express
vif
vpr
vpu
accessori
protein
rev
addit
stabil
transport
unsplic
viral
mrna
encod
gag
gagpolderiv
protein
unsplic
hiv
mrna
serv
viral
genom
rna
packag
within
viral
particl
releas
reinfect
host
current
unknown
mrna
stabil
process
involv
nucleolar
pathway
mediat
nucleocytoplasm
activ
rev
revnol
singlepoint
mutat
delet
correspond
nucleolarloc
induc
within
backbon
mrna
splice
observ
result
nucleolar
mutat
understand
role
nucleolu
viral
mrna
splice
singlepoint
mutat
incorpor
glycin
replac
arginin
residu
induc
within
cdna
revnol
motif
delet
last
two
amino
acid
revnol
also
gener
express
plasmid
contain
revnol
mutat
transfect
total
rna
collect
h
later
total
rna
lg
subject
northern
blot
analysi
detect
hiv
splice
variant
unsplic
kb
partial
splice
kb
unsplic
kb
use
radiolabel
probe
specif
nef
fig
ribosom
rna
load
control
captur
blot
transfer
use
standard
densitometri
three
independ
experiment
blot
unpair
ttest
n
use
statist
analys
wt
mrna
versu
revnol
mutant
mrna
rel
densiti
unsplic
revnol
variant
express
reduc
significantli
comparison
unsplic
wt
mrna
unsplic
mrna
similar
express
unsplic
wt
mrna
fig
partial
splice
mrna
wt
revnol
variant
similar
rel
densiti
unlik
abund
mrna
fig
fulli
splice
mrna
significantli
abund
compar
fulli
splice
wt
mrna
fig
rel
densiti
compar
fulli
splice
wt
mrna
ratio
despit
nucleolar
mutat
particl
resembl
wt
abil
replic
packag
intravir
rna
next
test
abil
mutant
viral
particl
achiev
host
cell
entri
quantifi
intravir
egfpvpr
infecti
transfer
direct
cellular
uptak
virion
surfac
receptor
observ
fluoresc
microscopi
copackag
egfpvpr
fusion
protein
creat
gfp
hiv
particl
egfpvpr
later
util
monitor
virion
uptak
hela
cell
nef
regul
viral
entri
host
cytoplasm
thu
implement
techniqu
quantifi
cellular
uptak
gfp
particl
copackag
revnol
variant
cdnawt
revnol
variantswa
copackag
egfpvpr
vector
propag
fluoresc
viral
particl
cem
hela
cell
subject
infect
lg
supernat
h
preserv
quantifi
egfp
posit
use
fac
analysi
despit
nucleolar
singlepoint
mutat
viral
particl
capabl
host
cell
entri
wt
cem
supplementari
fig
hela
cell
supplementari
fig
quantif
host
cell
contain
fluoresc
background
compar
pcdna
control
revnol
singlepoint
mutant
particl
abl
achiev
revers
transcript
mutat
correspond
revnol
nucleolar
patternwer
gener
within
cdna
use
propag
viru
cultur
singlepoint
particl
normal
ng
supernat
examin
intravir
function
revers
transcriptas
rt
use
colorimetr
rt
kit
variant
abl
produc
packag
function
rt
unlik
pcdna
neg
control
absent
rt
activ
supplementari
fig
colorimetr
valu
repres
dna
concentr
ng
releas
rt
viral
particl
revers
transcript
thereaft
anoth
test
viral
entri
revers
transcript
integr
viru
packag
revnol
variant
design
new
system
base
abil
detect
viral
entri
use
viru
carri
egfpvpr
fusion
protein
creat
report
cell
line
cell
integr
loxpmcfploxptagrfp
gene
cassett
would
undergo
mcfp
cyan
tagrfp
red
convers
upon
deliveri
express
cre
protein
fig
new
system
want
test
viral
entri
revers
transcript
transgen
integr
infect
cell
thu
creat
crevpr
fusion
protein
express
tatrespons
lentivir
vector
hiv
ltrcrevpr
fusionirestatgfp
fusion
cvitg
fig
therefor
entri
cvitg
viru
carri
crevpr
fusion
protein
would
induc
convers
mcfp
express
tagrfp
express
success
integr
cvitg
viru
would
also
lead
gfp
product
cvitg
lentivir
vector
coexpress
packag
vector
includ
aflagtag
revnol
mutat
partial
splice
mrna
contain
env
vif
vpr
gene
rel
densiti
compar
wt
fulli
splice
mrna
express
compar
revnol
variant
p
valu
p
valu
fulli
splice
mrna
contain
tat
rev
nef
gene
p
p
p
arizala
et
al
viral
supernat
collect
h
later
quantifi
use
elisa
antigen
captur
assay
revnol
mutat
function
cvitg
lentivir
product
yet
effici
wt
rev
fig
creloxp
recombin
report
cell
transduc
lg
cvitg
crevpr
lentiviru
produc
use
wt
revnol
mutat
cyan
fluoresc
protein
cfp
transit
red
fluoresc
protein
rfp
lentivir
transduct
addit
gfp
fluoresc
integr
assess
use
fac
analysi
experi
observ
cvitg
viru
copackag
rev
variant
abl
induc
tagrfp
express
extrem
low
frequencyan
indic
lentivir
entri
fig
e
cvitg
viru
copackag
rev
variant
also
abl
induc
tatgfp
express
extrem
low
frequencyan
indic
lentivir
revers
transcript
integr
supplementari
fig
b
small
fraction
cell
lentiviru
copackag
rev
variant
induc
viral
entri
revers
transcript
integr
similar
pcdna
neg
control
control
experi
use
wt
rev
rt
inhibitor
azidothymidin
azt
andor
integras
inhibitor
demonstr
function
system
detect
either
viral
entri
rfp
gfpcell
fig
g
express
cre
integr
rfp
gfp
cell
supplementari
fig
supernat
wt
revnol
variant
normal
ng
capsid
infect
popul
cell
per
well
tissu
cultur
plate
cell
harvest
genom
dna
start
h
postinfect
genom
dna
sampl
dilut
lgml
quantifi
integr
viral
dna
use
twostep
alugag
pcr
describ
previous
copi
number
integr
viral
dna
calcul
use
standard
curv
obtain
integr
standard
consist
infect
wt
viral
integr
variant
occur
extrem
higher
frequenc
wt
begin
h
infect
fig
variant
exhibit
similar
integr
copi
wt
integr
copi
detect
lower
frequenc
start
h
postinfect
continu
decreas
gradual
time
point
viral
infect
supernat
pcdna
use
neg
control
integr
studi
nucleolar
high
affin
revnol
function
nucleolar
local
rev
nucleocytoplasm
transport
revbound
hiv
mrna
affin
rev
contain
singlepoint
arginin
substitut
delet
assess
immunoprecipit
ip
wt
mutat
western
immunoblot
hlfb
transfect
revnol
mutat
protein
extract
ip
reaction
mgml
collect
hlfb
h
product
ip
eluat
subject
western
immunoblot
use
monoclon
antibodi
specif
aflagrev
fig
c
fig
background
rev
singlepoint
mutat
revnol
bind
affin
significantli
reduc
fig
maintain
affin
wt
rev
hiv
product
column
repres
sampl
size
three
ip
experi
compar
unpair
ttest
delet
amino
acid
rqrq
ctermin
end
revnol
maintain
nucleolar
accumul
cultur
delet
entir
revnol
amino
acid
wrerqrq
caus
intracellular
dispers
rev
current
model
remov
amino
acid
revegfp
result
nucleolarnuclear
accumul
rev
product
hela
cultur
express
revdefici
provir
similarli
nucleolarnuclear
accumul
observ
upon
remov
entir
nol
differ
subcellular
local
previou
studi
comparison
observ
attribut
presenc
product
model
absenc
viral
product
hela
cultur
remov
amino
acid
fig
creloxp
dual
fluoresc
report
indic
lentivir
entri
revers
transcript
integr
background
revnol
mutat
report
cell
line
gener
test
viral
entri
revers
transcript
transgen
integr
report
contain
loxpmcfploxptagrfp
xcxr
gene
cassett
undergo
convers
mcfp
cyan
tagrfp
red
upon
viral
deliveri
cre
protein
viral
deliveri
system
packag
crevpr
fusion
protein
express
tatrespons
lentivir
vector
hiv
ltrcrevpr
fusionirestat
gfp
fusion
cvitg
b
cvitg
lentivir
vector
coexpress
gagpol
vsvg
packag
vector
aflagtag
revnol
mutat
viral
supernat
collect
h
later
quantifi
use
elisa
antigen
captur
assay
revnol
mutat
function
lentivir
product
effici
wt
rev
c
xcxr
transduc
lg
cvitg
crevpr
lentiviru
cfp
transit
rfp
lentivir
transduct
assess
use
fac
analysi
day
posttransduct
cvitg
lentiviru
copackag
rev
variant
induc
tagrfp
express
extrem
low
frequenc
indic
lentivir
entri
e
control
experi
use
wt
rev
revers
transcriptas
inhibitor
azt
andor
integras
inhibitor
serv
neg
control
cvitg
transduct
demonstr
function
system
detect
viral
entri
revers
transcript
integr
f
g
repres
addit
cell
popul
use
neg
control
rfp
cfp
express
xcxr
repres
neg
control
popul
report
cell
transduc
cvitg
lentiviru
azt
azidothymidin
cfp
cyan
fluoresc
protein
rfp
red
fluoresc
protein
nol
studi
rev
result
nucleolar
accumul
previous
observ
cell
remov
amino
acid
studi
caus
nuclear
dispers
also
previous
observ
without
product
rev
mutat
contain
two
arginin
residu
within
nol
motif
exclus
nucleolar
pattern
revnol
wt
rev
origin
contain
three
arginin
residu
within
nol
motif
current
demonstr
depend
rev
nucleolar
accumul
presenc
least
two
arginin
residu
within
revnol
nucleolar
local
rev
rex
previous
demonstr
unnecessari
accumul
cytoplasm
unsplic
rna
tether
rna
oper
fusion
absenc
viral
respons
element
nucleolar
traffick
therefor
believ
occur
high
affin
viral
protein
nucleolar
constitu
describ
unessenti
rev
activ
investig
signific
rev
nucleolar
traffick
local
hiv
product
model
rescu
revdefici
revnol
mutat
contrast
previou
find
reveal
rev
mutat
lack
nucleolar
entri
nonfunct
hiv
prolifer
viral
rna
packag
partial
nuclear
nucleolar
local
rescu
viral
product
mutat
lack
two
arginin
residu
within
revnol
seuqenc
lack
three
arginin
residu
would
lead
conform
chang
within
ahel
structur
revnol
interrupt
revrr
bind
activ
nonfunct
activ
rescu
viral
product
could
attribut
inabl
rev
mutat
bind
rre
mrna
strictli
nucleolar
rev
mutat
function
viral
product
howev
reduc
effici
compar
wt
rev
nucleolarloc
contain
two
miss
amino
acid
nol
arg
gln
result
defect
viral
product
insuffici
rescu
viral
product
viral
rna
packag
despit
nucleolar
access
provid
evid
infect
also
depend
effici
splice
transport
mrnaboth
process
take
place
within
nucleolu
substitut
arginin
residu
carboxyl
terminu
rev
nl
alanin
arg
arg
arg
previous
demonstr
reduc
revrr
bind
threefold
observ
yield
similar
result
upon
substitut
arginin
residu
glycin
capsid
express
origin
unsplic
mrna
transport
cytosol
revrr
interact
observ
decreas
express
revdefici
model
upon
viral
product
express
nucleolarloc
singlepoint
mutat
revnol
comparison
wt
rev
singlepoint
mutat
led
threefold
decreas
protein
well
decreas
packag
genom
rna
mutat
arginin
residu
similar
basic
amino
acidlysinedid
affect
revrr
bind
arg
arg
arg
carboxyl
terminu
rev
arm
moder
import
phosphat
van
der
waal
interact
rev
rre
mrna
interact
stabil
ahel
orient
rev
arm
within
rre
rna
groov
inabl
nucleolarloc
revnol
rescu
rev
defici
viral
product
postul
result
two
miss
amino
acid
nol
motif
arg
gln
would
lead
destabil
rev
arm
rre
revnol
delet
would
addit
lead
loss
nucleolarspecif
protein
interact
revnol
inabl
rescu
viral
product
genom
rna
packag
despit
nucleolar
access
reveal
rev
nucleolar
local
insuffici
progress
infecti
cycl
infect
may
abl
manipul
host
cellular
pathway
subnuclear
level
nucleolar
access
simpl
explan
rev
function
misplac
protein
interact
nucleolarloc
revnol
mutat
comparison
wt
rev
could
identifi
nucleolar
pathway
requir
product
viral
particl
gener
background
revnol
singlepoint
mutat
capabl
transduct
infect
extrem
low
frequenc
vsvgpseudotyp
lentiviru
gener
revnol
mutat
replic
yet
lack
transduc
similarli
mutat
introduc
cdna
hinder
viral
product
yet
result
inabl
variant
infect
host
cell
quantifi
potenc
revnol
singlepoint
mutat
viral
infect
viral
output
day
postinfect
mutant
viru
lack
abil
regain
function
particip
viral
infecti
cycl
unlik
revnol
singlepoint
mutat
acquir
within
tat
basic
rkkrrqrrrahq
requir
tar
rna
bind
nl
nol
product
day
comparison
wt
tat
singlepoint
mutat
significantli
affect
tat
function
transactiv
viral
gene
mrna
splice
involv
interplay
core
splice
signal
exonicintron
splice
enhanc
silenc
secondari
structur
premrna
core
splice
signal
compos
follow
three
site
commonli
found
premrna
site
site
branch
point
sequenc
bp
recruit
splice
factor
snrnp
allow
interact
anoth
splice
bp
bind
branch
point
bind
protein
later
displac
snrnp
format
spliceosom
complex
categor
pair
throughout
mammalian
premrna
classifi
strong
weak
splice
site
base
affin
correspond
splice
factor
snrna
bp
exon
definit
bridg
lead
format
earli
irrevers
splice
complex
e
complex
result
splice
reaction
core
splice
signal
surround
cisel
either
enhanc
exon
splice
enhanc
ese
repress
exon
splice
silenc
esss
exon
definit
altern
splice
reaction
ese
sequenc
element
within
exon
interact
serineargininerich
splice
factor
sr
protein
esss
interact
heterogen
ribonuclear
splice
inhibitor
hnrnp
repress
exon
definit
intron
splice
silenc
isss
intron
splice
enhanc
sequenc
within
intron
facilit
exon
definit
premrna
secondari
structur
abl
modul
altern
splice
reaction
exposur
core
splice
signal
regulatori
cisel
accumul
partial
splice
unsplic
viral
mrna
depend
presenc
rre
locat
supplementari
fig
mrna
encod
vif
vpr
tat
express
extrem
low
level
indic
infrequ
activ
partial
splice
kb
vif
mrna
product
compos
incomplet
splice
viral
mrna
infect
cell
vpr
mrna
product
compos
total
partial
splice
mrna
approxim
half
splice
viral
mrna
fulli
splice
kb
mrna
indic
frequent
splice
tat
mrna
compos
complet
splice
mrna
twoexon
tat
partial
splice
mrna
oneexon
tat
tat
mrna
form
splice
activ
transcript
lead
vpu
env
rev
abundantli
express
indic
frequent
use
center
premrna
contain
cluster
lead
accumul
fulli
splice
rev
mrna
fulli
splice
nef
mrna
partial
splice
env
vpu
mrna
cluster
popul
compos
complet
splice
mrna
partial
splice
mrna
altern
mrna
lead
express
twoexon
tat
rev
nef
util
effici
splice
activ
requir
ess
ese
iss
element
novel
identifi
within
gagpol
mrna
util
low
frequenc
compar
splice
site
within
premrna
suggest
necessari
featur
prevent
degrad
unsplic
viral
mrna
snrnp
bound
recruit
sr
protein
may
stabil
bind
rev
viral
rna
lead
nuclear
export
unsplic
rna
base
observ
rev
mutat
inabl
lentiviru
replic
packag
mrna
may
result
singlepoint
mutat
defect
affect
rev
rre
bind
nucleocytoplasm
transport
specif
arg
arg
rev
arm
interact
nucleotid
rre
major
groov
asn
arg
interact
opposit
major
groov
arg
arg
arg
cooh
terminu
rev
arm
suggest
moder
import
specif
bind
achiev
phosphat
van
der
waal
contact
ahel
orient
within
rre
groov
studi
substitut
rev
arg
arg
arg
glycin
within
provir
cdna
lead
spliceosom
irregular
kb
mrna
variant
significantli
reduc
express
compar
wt
arg
gln
delet
within
variant
exhibit
abund
kb
mrna
wt
find
exemplifi
import
revnol
rre
bind
mrna
transport
observ
rev
singlepoint
mutat
decreas
cytoplasm
export
kb
mrna
therebi
lead
decreas
product
sinc
deriv
gagpol
precursor
kb
mrna
two
amino
acid
delet
significantli
chang
level
kb
mrna
although
disproportion
higher
level
kb
mrna
splice
variant
observ
impair
rev
facilit
nucleocytoplasm
transport
unsplic
partial
splice
transcript
could
result
accumul
fulli
splice
kb
transcript
encod
tat
rev
nef
protein
therefor
increas
tat
express
would
activ
tatposit
feedback
loop
lead
enhanc
transactiv
hiv
gene
express
subsequ
accumul
kb
mrna
also
consist
comput
model
predict
increas
kb
transcript
upon
inhibit
rev
proportion
splicedunspl
mrna
variant
may
prerequisit
viral
product
infect
addit
host
cell
protein
interact
rev
nucleolu
may
regul
hiv
mrna
transport
splice
nucleolar
involv
nucleocytoplasm
shuttl
revbound
hiv
mrna
well
character
interact
nol
host
growth
factor
amino
acid
prerrna
processor
amino
acid
retrovir
protein
rex
amino
acid
tat
amino
acid
current
reveal
revnol
singlepoint
mutat
abolish
interact
rev
may
lead
disrupt
nucleocytoplasm
shuttl
hiv
mrna
also
reveal
loss
interact
rev
hinder
viral
product
yet
diminish
viral
infect
suggest
nucleolar
factor
involv
viral
product
revnol
viral
entri
revers
transcript
integr
rev
singlepoint
mutat
demonstr
allow
entri
egfpvprlabel
particl
host
cell
postul
defect
product
presenc
nucleolar
mutat
occur
postentri
revers
transcript
andor
integr
revnol
mutant
exhibit
reduc
express
capsid
rt
packag
rna
would
result
reduc
express
gagpol
precursor
well
c
packag
element
origin
kb
hiv
mrna
presenc
singlepoint
mutat
rev
mutant
produc
capsid
rt
packag
rna
extrem
low
quantiti
comparison
mutant
would
result
constant
splice
kb
mrna
accumul
kb
mrna
fragment
presenc
nonfunct
rev
nullbas
transdomin
neg
mutat
tat
contain
glycinealanin
substitut
tat
basic
domain
amino
acid
nullbas
demonstr
reduc
infect
magi
jurkat
human
primari
cell
revers
transcript
mechan
nullbas
interrupt
revers
transcript
unclear
nullbas
tat
demonstr
redistribut
nucleolar
rev
cytoplasm
downregul
revmedi
mrna
transport
express
gagderiv
protein
nullbas
coexpress
rev
caus
dispers
nucleolar
nucleolin
nucleu
absenc
tat
basic
domain
nullbas
interact
would
suggest
altern
indirect
interact
tat
rev
besid
mutat
within
revnol
may
turn
interrupt
tat
function
unknown
pathway
identif
host
factor
involv
mechan
would
explain
revers
transcript
defici
presenc
nullbas
tat
well
revnol
singlepoint
mutat
altern
nucleolar
factor
may
requir
within
viral
particl
directli
facilit
revers
transcript
postentri
reduct
cellular
factor
revnol
mutat
could
lead
defect
reduct
revers
transcript
lentiviru
gener
background
revnol
singlepoint
mutat
transduc
host
cell
howev
extrem
low
frequenc
comparison
wt
lentiviru
transduc
model
defin
abil
lentiviru
achiev
host
cell
entri
revers
transcript
integr
event
quantifi
report
place
within
lentivir
backbon
contain
gfp
report
detect
revers
transcript
integr
cvitg
contain
gfp
detect
revers
transcript
integr
produc
cre
induc
creloxpdepend
cleavag
stabli
express
loxpcfploxprfp
report
detect
lentivir
entri
host
inabl
cvitg
lentiviru
fulli
transduc
host
cell
presenc
revnol
mutat
reveal
defici
integr
step
separ
infecti
model
defici
integr
observ
upon
inabl
variant
integr
host
prevent
tatinduc
activ
intern
ltregfp
report
previou
studi
demonstr
intracellular
interact
integras
rev
use
bimolecular
fluoresc
complement
coip
assay
system
rev
protein
initi
transcrib
unintegr
viral
dna
earli
stage
infect
integr
step
occur
believ
inhibitori
effect
enzymat
activ
integras
cell
typic
contain
limit
number
integr
viral
genom
per
host
cellnam
one
two
integr
event
observ
sever
integr
event
document
retrovirusesmurin
leukemia
viru
rou
sarcoma
virussuggest
differ
regulatori
mechan
viral
integr
retrovir
model
two
integrasederiv
peptid
shown
diminish
inhibitori
effect
rev
integras
activ
stimul
multipl
viral
dna
integr
event
kinet
studi
find
suggest
involv
rev
nucleolar
pathway
regul
lentivir
integr
format
len
epitheliumderiv
growth
factor
complex
rev
previous
observ
crucial
step
regul
viral
cdna
integr
coip
experi
reveal
complex
form
postinfect
later
replac
revin
complex
nucleolar
singlepoint
mutat
name
background
may
hinder
revdepend
regul
integras
would
result
high
frequenc
viral
integr
observ
studi
singlepoint
mutat
induc
within
revnol
expect
decreas
bind
affin
cellular
host
factor
facilit
rev
function
hiv
mrna
bind
transport
nucleolar
involv
nucleocytoplasm
shuttl
revbound
mrna
revnol
singlepoint
mutat
model
abolish
affin
rev
indic
disrupt
nucleocytoplasm
shuttl
hiv
mrna
transport
disrupt
interact
rev
turn
hinder
viral
product
yet
diminish
abil
produc
infecti
viral
particl
postul
nucleolar
factor
transport
factor
splice
factor
involv
function
particip
infecti
cycl
transport
nucleolar
viral
protein
viral
assembl
encapsid
product
latenc
document
viral
infecti
model
character
interact
nol
cellular
factor
nucleocytoplasm
growth
factor
amino
acid
prerrna
processor
amino
acid
retrovir
protein
rex
amino
acid
tat
amino
acid
rev
amino
acid
juvenil
enceph
viru
jev
infect
transmit
mosquito
vector
lead
acut
enceph
human
jev
genom
encod
nucleolarloc
core
protein
amino
acid
interact
ntermin
region
jev
infect
result
transport
viral
core
nucleu
singlestrand
rna
hbv
caus
cirrhosi
hepatocellular
carcinoma
infect
hbv
genom
compos
partial
doublestrand
dna
encod
nucleolar
core
protein
hbv
core
protein
associ
nucleolin
nucleolu
demonstr
hbv
assembl
interact
core
protein
ntermin
domain
specif
amino
acid
bind
ntermin
domain
hbv
core
protein
allow
viral
encapsid
negativesens
singlestrand
rna
hepat
viru
hdv
express
hdvag
antigen
two
isoform
small
isoform
aid
rna
replic
larg
isoform
facilit
viral
assembl
rna
replic
take
place
within
nucleolu
requir
interact
hdvag
hdv
infect
caus
upregul
interact
mostli
small
hdvag
isoform
less
larg
hdvag
isoform
interact
take
place
small
hdvag
nl
domain
bind
achiev
nuclear
accumul
upon
delet
hdv
bind
site
rna
replic
impair
hdvag
shown
coloc
nucleolin
nucleolu
nucleolin
discov
possess
transcript
properti
repressor
reveal
nucleolu
compart
regul
hdv
replic
involv
latenc
doublestrand
dna
kaposi
sarcoma
herpesviru
kshv
lead
kaposi
sarcoma
associ
aidsinduc
nonhodgkin
lymphoma
kshv
latent
proteinvcyclinwith
host
kinas
phosphoryl
facilit
interact
latencyassoci
nuclear
antigen
latencyassoci
nuclear
antigen
act
prevent
viral
lytic
replic
deplet
lead
kshv
reactiv
reveal
regul
kshv
latenc
function
hiv
product
cycl
character
nucleocytoplasm
transport
activ
tat
rev
unknown
induc
latenc
hiv
infect
involv
product
encapsid
assembl
hiv
also
unknown
current
demonstr
rev
nucleolar
access
requir
product
pathogenesi
local
pattern
allow
effici
mrna
splice
nucleocytoplasm
transport
reveal
extra
step
infecti
cycl
nucleolu
rev
nucleocytoplasm
activ
requir
product
infecti
viral
particl
interfer
nucleolar
activ
mutat
revnol
diminish
abil
regul
viral
integr
within
host
cell
therebi
lead
host
cell
death
termin
viral
infecti
cycl
summari
find
util
nucleolar
pathway
maintain
infecti
cycl
find
suggest
understudi
pathway
novel
therapeut
target
interfer
infect
nucleolar
manipul
could
applic
viral
infect
diseas
model
requir
nucleolar
access
